March 10, 2009 — Metagenics Inc. announced it has launched a new nutraceutical called Ostera. This unique nutritional supplement supports the special needs of postmenopausal women, whose bone health may be affected by declining estrogen levels.
Ostera is formulated to target bone remodeling, the normal lifelong process whereby old or damaged bone tissue is replaced by new bone tissue. Conventional approaches to postmenopausal bone health may have adverse affects or not be well-tolerated. By contrast, Ostera is a gentle, all-natural formula without reported serious adverse effects. Ostera is intended to complement natural bone mineralization support products, such as calcium and other minerals.
Source: Metagenics Inc., www.metagenics.com
Related Posts
Leaning into a cash practice chiropractic clinic- Lockdown dieting: Mediterranean diet vs keto for patients
- New study finds no evidence that maximum lifespan has stopped increasing
- Kentucky, lone state to close chiropractic, will conditionally reopen offices on Monday
- New peach scented pain-relief cream released
- Renting office space: 8 issues to watch for
